Literature DB >> 22019059

A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein.

Hisato Takagi, Takuya Umemoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22019059     DOI： 10.1016/j.ijcard.2011.09.065

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

1.  Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study.

Authors:  Panagiotis Anagnostis; Fotini Adamidou; Aristidis Slavakis; Stergios A Polyzos; Despina Selalmatzidou; Athanasios Panagiotou; Vasilios G Athyros; Asterios Karagiannis; Marina Kita
Journal:  Open Cardiovasc Med J       Date:  2014-07-11

2.  No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.

Authors:  Muaamar Al-Gobari; Hai-Ha Le; Mor Fall; François Gueyffier; Bernard Burnand
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.